PARTIAL FATTY ACID OXIDATION (P-FOX) INHIBITORS AND COMBINED THERAPY OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
.
Saved in:
| Main Authors: | M. E. Statsenko, S. V. Turkina, S. N. Tolstov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2011-04-01
|
| Series: | Российский кардиологический журнал |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1156 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MEXICOR IN THE COMBINATION THERAPY OF CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2011-12-01) -
EFFECTS OF MILDRONATE, AS A PART OF COMBINED HEART FAILURE THERAPY, ON CARBOHYDRATE AND LIPID METABOLISM AND OXIDATIVE STRESS PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2010-04-01) -
The metabolism of fatty acids and insulin secretion in children with type 1 diabetes mellitus and its complications
by: N. P. Mikaelyan, et al.
Published: (2021-06-01) -
The Influence of Non-Alc oholic Fatty Liver Disease on Indicators of Arterial Stiffness and Risk of Cardiovascular Complications in Patients with Arterial Hypertension
by: M. E. Statsenko, et al.
Published: (2020-07-01) -
Emerging roles for fatty acid oxidation in cancer
by: Jialin Ma, et al.
Published: (2025-07-01)